Ben David H - Search Results

1

Development of a topical bacteriophage gel targeting Cutibacterium acnes for acne prone skin and results of a phase 1 cosmetic randomized clinical trial.

Golembo M, Puttagunta S, Rappo U, Weinstock E, Engelstein R, Gahali-Sass I, Moses A, Kario E, Ben-Dor Cohen E, Nicenboim J, Ben David H, Sudakov K, Cohen A, Bassan M, Zak NB. Golembo M, et al. Among authors: ben david h. Skin Health Dis. 2022 Jan 28;2(2):e93. doi: 10.1002/ski2.93. eCollection 2022 Jun. Skin Health Dis. 2022. PMID: 35677920 Free PMC article.

2

Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation.

Federici S, Kredo-Russo S, Valdés-Mas R, Kviatcovsky D, Weinstock E, Matiuhin Y, Silberberg Y, Atarashi K, Furuichi M, Oka A, Liu B, Fibelman M, Weiner IN, Khabra E, Cullin N, Ben-Yishai N, Inbar D, Ben-David H, Nicenboim J, Kowalsman N, Lieb W, Kario E, Cohen T, Geffen YF, Zelcbuch L, Cohen A, Rappo U, Gahali-Sass I, Golembo M, Lev V, Dori-Bachash M, Shapiro H, Moresi C, Cuevas-Sierra A, Mohapatra G, Kern L, Zheng D, Nobs SP, Suez J, Stettner N, Harmelin A, Zak N, Puttagunta S, Bassan M, Honda K, Sokol H, Bang C, Franke A, Schramm C, Maharshak N, Sartor RB, Sorek R, Elinav E. Federici S, et al. Among authors: ben david h. Cell. 2022 Aug 4;185(16):2879-2898.e24. doi: 10.1016/j.cell.2022.07.003. Epub 2022 Aug 4. Cell. 2022. PMID: 35931020 Free article.

3

A 50-kDa ERK-like protein is up-regulated by a dual altered peptide ligand that suppresses myasthenia gravis-associated responses.

Ben-David H, Aruna BV, Seger R, Sela M, Mozes E. Ben-David H, et al. Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18232-7. doi: 10.1073/pnas.0608896103. Epub 2006 Nov 15. Proc Natl Acad Sci U S A. 2006. PMID: 17108079 Free PMC article.

4

A dual altered peptide ligand inhibits myasthenia gravis associated responses by inducing phosphorylated extracellular-regulated kinase 1,2 that upregulates CD4+CD25+Foxp3+ cells.

Ben-David H, Venkata Aruna B, Sela M, Mozes E. Ben-David H, et al. Scand J Immunol. 2007 Jun;65(6):567-76. doi: 10.1111/j.1365-3083.2007.01940.x. Scand J Immunol. 2007. PMID: 17523950 Free article.

5

The role of CD8+CD28 regulatory cells in suppressing myasthenia gravis-associated responses by a dual altered peptide ligand.

Ben-David H, Sharabi A, Dayan M, Sela M, Mozes E. Ben-David H, et al. Proc Natl Acad Sci U S A. 2007 Oct 30;104(44):17459-64. doi: 10.1073/pnas.0708577104. Epub 2007 Oct 23. Proc Natl Acad Sci U S A. 2007. PMID: 17956982 Free PMC article.

6

A tolerogenic peptide down-regulates mature B cells in bone marrow of lupus-afflicted mice by inhibition of interleukin-7, leading to apoptosis.

Ben-David H, Sharabi A, Parameswaran R, Zinger H, Mozes E. Ben-David H, et al. Immunology. 2009 Oct;128(2):245-52. doi: 10.1111/j.1365-2567.2009.03109.x. Immunology. 2009. PMID: 19740381 Free PMC article.

7

A role for the B-cell CD74/macrophage migration inhibitory factor pathway in the immunomodulation of systemic lupus erythematosus by a therapeutic tolerogenic peptide.

Lapter S, Ben-David H, Sharabi A, Zinger H, Telerman A, Gordin M, Leng L, Bucala R, Shachar I, Mozes E. Lapter S, et al. Among authors: ben david h. Immunology. 2011 Jan;132(1):87-95. doi: 10.1111/j.1365-2567.2010.03342.x. Epub 2010 Aug 25. Immunology. 2011. PMID: 20738420 Free PMC article.

8

A dual altered peptide ligand down-regulates myasthenogenic T cell responses and reverses experimental autoimmune myasthenia gravis via up-regulation of Fas-FasL-mediated apoptosis.

Aruna BV, Ben-David H, Sela M, Mozes E. Aruna BV, et al. Among authors: ben david h. Immunology. 2006 Jul;118(3):413-24. doi: 10.1111/j.1365-2567.2006.02398.x. Immunology. 2006. PMID: 16827902 Free PMC article.

9

B-cell activating factor (BAFF) plays a role in the mechanism of action of a tolerogenic peptide that ameliorates lupus.

Parameswaran R, Ben David H, Sharabi A, Zinger H, Mozes E. Parameswaran R, et al. Among authors: ben david h. Clin Immunol. 2009 May;131(2):223-32. doi: 10.1016/j.clim.2008.12.009. Epub 2009 Feb 1. Clin Immunol. 2009. PMID: 19188092

10

Down-regulation of myasthenogenic T cell responses by a dual altered peptide ligand via CD4+CD25+-regulated events leading to apoptosis.

Ben-David H, Sela M, Mozes E. Ben-David H, et al. Proc Natl Acad Sci U S A. 2005 Feb 8;102(6):2028-33. doi: 10.1073/pnas.0409549102. Epub 2005 Jan 26. Proc Natl Acad Sci U S A. 2005. PMID: 15677327 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page